Home/Topic Collection

Topic Collection

Advances in Clinical Psychopharmacology in Children and Young People

Submission Deadline: 28th November 2023 We are pleased to offer a 25% discount on the Article Processing Charge (APC) for articles submitted to this Topic Collection. Please visit our author hub for more information about the benefits of submitting to a Topic Collection Clinical psychopharmacology is a developing field with relevant unmet needs and opportunities. Such as understanding the best use of currently available medications, gaining insight into their specific effects in the developmental stage of life, and the testing of new medications. This Topic Collection of BMJ Mental Health will publish high quality empirical original studies or evidence synthesis papers on any relevant aspect of clinical psychopharmacology in children and/or young people.  This includes among other topics:
  • Pharmacokinetics and/or pharmacodynamics
  • Utilization
  • Special populations
  • Efficacy
  • Effectiveness
  • Quality of life, functioning, patient reported outcomes
  • Acceptability
  • Safety/tolerability
  • Non-adherence
  • Policy
  • Guidelines
  • Implementation of evidence-based treatments
  • Comorbidities
  • Transdiagnostic Approaches
Analyses of randomised controlled trials, pharmacoepidemiologic studies, meta- and umbrella reviews are particularly welcome. Please see the instructions for authors for submission requirements for each article type. To submit your article, please follow these instructions and select ‘Advances in Clinical Psychopharmacology in Children and Young People’ as the Topic Collection.   All submitted articles will be subject to the journal's normal peer review process. Articles accepted for publication will be published upon acceptance. Visit our author hub for more information regarding the publication process for Topic Collections.  Key words: Psychopharmacology, Children, Adolescents, Young People; randomised controlled trials; ADHD; Autistic Spectrum Disorder; anxiety disorders; obsessive compulsive disorder; major depressive disorder; antidepressants; SSRIs; SRNIs; TCAs; antipsychotics

Guest Editors

Samuele Cortese University of Southampton ORCID logo orcid.org/0000-0001-5877-8075 Carmen Moreno Hospital General Universitario Gregorio Marañón ORCID logo orcid.org/0000-0003-0541-4846